MediSpend is Enterprise Systems (Healthcare) in United States that focus on software aids pharmaceutical business. Founded in 1995. They cover business area such as developer, compliance and business intelligence software, medical device, biopharmaceutical company, global health care law, transparency, enable companiesto, high-risk business function.
Enterprise Systems (Healthcare)
1995
( 29 years old in 2024 )
Software Aids Pharmaceutical
-
100 International Drive
Suite 350
Portsmouth, NH 03801
United States
Private
developercompliance and business intelligence softwaremedical devicebiopharmaceutical companyglobal health care lawtransparencyenable companiestohigh-risk business function
* We use standard office opening hours in near MediSpend's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MediSpend is Enterprise Systems (Healthcare) business from United States that founded in 1995 (29 years old in 2024), MediSpend business is focusing on Software Aids Pharmaceutical.
MediSpend headquarter office and corporate office address is located in 100 International Drive Suite 350 Portsmouth, NH 03801 United States.
MediSpend was founded in United States.
In 2024, MediSpend is currently focus on software aids pharmaceutical sector.
Above is snippet of Google Trends for "software aids pharmaceutical" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MediSpend, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.